Connor, Clark & Lunn Investment Management (CC&L)’s MiMedx Group MDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $881K | Buy |
144,166
+8,272
| +6% | +$50.5K | ﹤0.01% | 1087 |
|
|
2025
Q1 | $1.03M | Buy |
135,894
+27,899
| +26% | +$212K | ﹤0.01% | 937 |
|
|
2024
Q4 | $1.04M | Sell |
107,995
-164,405
| -60% | -$1.58M | ﹤0.01% | 918 |
|
|
2024
Q3 | $1.61M | Sell |
272,400
-33,659
| -11% | -$199K | 0.01% | 721 |
|
|
2024
Q2 | $2.12M | Sell |
306,059
-4,793
| -2% | -$33.2K | 0.01% | 639 |
|
|
2024
Q1 | $2.39M | Sell |
310,852
-84,532
| -21% | -$651K | 0.01% | 622 |
|
|
2023
Q4 | $3.47M | Sell |
395,384
-26,287
| -6% | -$231K | 0.02% | 526 |
|
|
2023
Q3 | $3.07M | Sell |
421,671
-10,528
| -2% | -$76.7K | 0.02% | 510 |
|
|
2023
Q2 | $2.86M | Buy |
432,199
+393,655
| +1,021% | +$2.6M | 0.01% | 513 |
|
|
2023
Q1 | $131K | Buy |
+38,544
| New | +$131K | ﹤0.01% | 1133 |
|
|
2021
Q4 | – | Sell |
-32,384
| Closed | -$196K | – | 1150 |
|
|
2021
Q3 | $196K | Buy |
+32,384
| New | +$196K | ﹤0.01% | 949 |
|